X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
administration, oral (1) 1
adult (1) 1
aged (1) 1
aged, 80 and over (1) 1
alcohol (1) 1
anticoagulants (1) 1
anticoagulants - administration & dosage (1) 1
anticoagulants - adverse effects (1) 1
antiplatelet agents (1) 1
atrial fibrillation (1) 1
atrial fibrillation - diagnosis (1) 1
atrial fibrillation - drug therapy (1) 1
atrial fibrillation - epidemiology (1) 1
cardiac arrhythmia (1) 1
codes (1) 1
comparative analysis (1) 1
diagnosis (1) 1
dosage and administration (1) 1
drug prescriptions (1) 1
drug therapy (1) 1
enrollments (1) 1
female (1) 1
fibrinolytic agents - administration & dosage (1) 1
fibrinolytic agents - adverse effects (1) 1
gender (1) 1
general practice - trends (1) 1
general practitioner (1) 1
general practitioners - trends (1) 1
health care surveys (1) 1
heart (1) 1
hospitals (1) 1
humans (1) 1
hypertension (1) 1
index medicus (1) 1
italy - epidemiology (1) 1
male (1) 1
medical care (1) 1
medication adherence (1) 1
middle aged (1) 1
nonsteroidal anti-inflammatory drugs (1) 1
oral anticoagulant (1) 1
original research (1) 1
patients (1) 1
platelet aggregation inhibitors - administration & dosage (1) 1
platelet aggregation inhibitors - adverse effects (1) 1
population (1) 1
practice patterns, physicians' - trends (1) 1
prescription drugs (1) 1
prevalence (1) 1
quality management (1) 1
real world (1) 1
retrospective studies (1) 1
stroke (1) 1
stroke - epidemiology (1) 1
stroke - prevention & control (1) 1
tax exemptions (1) 1
thromboembolism (1) 1
thrombolytic drugs (1) 1
time factors (1) 1
treatment outcome (1) 1
vascular health and risk management (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Vascular Health and Risk Management, ISSN 1176-6344, 07/2017, Volume 13, pp. 239 - 246
The aims of this study were to assess the prevalence of diagnosed atrial fibrillation (AF), the drug use in patients with AF in terms of antithrombotic (AT)... 
General practitioner | Oral anticoagulant | Real world | Atrial fibrillation | Antiplatelet agents | Prevalence | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Fibrinolytic Agents - adverse effects | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Adult | Female | Stroke - epidemiology | Retrospective Studies | General Practice - trends | Atrial Fibrillation - diagnosis | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Administration, Oral | Atrial Fibrillation - drug therapy | Treatment Outcome | Anticoagulants - adverse effects | Drug Prescriptions | Practice Patterns, Physicians' - trends | Medication Adherence | Atrial Fibrillation - epidemiology | Italy - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | General Practitioners - trends | Health Care Surveys | Medical care | Dosage and administration | Diagnosis | Thrombolytic drugs | Drug therapy | Comparative analysis | Quality management | Hypertension | Heart | Cardiac arrhythmia | Anticoagulants | Stroke | Codes | Enrollments | Alcohol | Gender | Patients | Prescription drugs | Hospitals | Databases | Population | Tax exemptions | Nonsteroidal anti-inflammatory drugs | Thromboembolism | general practitioner | atrial fibrillation | antiplatelet agents | real world | oral anticoagulant
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.